25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

FUM (Futura Medical) Stock Analysis
Buy, Hold or Sell?

Let's analyze Futura Medical together

I guess you are interested in Futura Medical. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Futura Medical’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Futura Medical’s Price Targets

I'm going to help you getting a better view of Futura Medical. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Futura Medical

I send you an email if I find something interesting about Futura Medical.

1. Quick Overview

1.1. Quick analysis of Futura Medical (30 sec.)










1.2. What can you expect buying and holding a share of Futura Medical? (30 sec.)

How much money do you get?

How much money do you get?
p0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
p2.88
Expected worth in 1 year
p7.21
How sure are you?
50.0%

+ What do you gain per year?

Total Gains per Share
p4.33
Return On Investment
55.1%

For what price can you sell your share?

Current Price per Share
p7.85
Expected price per share
p0 - p9.98
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Futura Medical (5 min.)




Live pricePrice per Share (EOD)
p7.85
Intrinsic Value Per Share
p-7.94 - p7.87
Total Value Per Share
p-5.05 - p10.76

2.2. Growth of Futura Medical (5 min.)




Is Futura Medical growing?

Current yearPrevious yearGrowGrow %
How rich?$12.2m$7.4m$4.7m38.9%

How much money is Futura Medical making?

Current yearPrevious yearGrowGrow %
Making money$1.7m-$8.8m$10.6m603.7%
Net Profit Margin9.3%-210.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Futura Medical (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#563 / 881

Most Revenue
#229 / 881

Most Profit
#129 / 881

Most Efficient
#127 / 881
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Futura Medical?

Welcome investor! Futura Medical's management wants to use your money to grow the business. In return you get a share of Futura Medical.

First you should know what it really means to hold a share of Futura Medical. And how you can make/lose money.

Speculation

The Price per Share of Futura Medical is p7.85. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Futura Medical.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Futura Medical, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is p2.88. Based on the TTM, the Book Value Change Per Share is p1.08 per quarter. Based on the YOY, the Book Value Change Per Share is p0.25 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is p0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Futura Medical.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 p% of Price per Sharep% of Price per Sharep% of Price per Sharep% of Price per Sharep% of Price per Sharep% of Price per Share
Usd Eps0.010.1%0.010.1%-0.03-0.4%-0.02-0.2%-0.02-0.2%-0.02-0.3%
Usd Book Value Change Per Share0.010.2%0.010.2%0.000.0%0.000.0%0.010.1%0.000.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.010.2%0.010.2%0.000.0%0.000.0%0.010.1%0.000.0%
Usd Price Per Share0.43-0.43-0.35-0.49-0.44-0.41-
Price to Earnings Ratio76.07-76.07--11.90-12.52--1.15--10.00-
Price-to-Total Gains Ratio29.26-29.26-102.31-33.50-34.38-7.19-
Price to Book Ratio10.97-10.97-14.15-19.36-24.93-95.39-
Price-to-Total Gains Ratio29.26-29.26-102.31-33.50-34.38-7.19-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.1071054
Number of shares9336
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.010.01
Usd Total Gains Per Share0.010.01
Gains per Quarter (9336 shares)137.7673.03
Gains per Year (9336 shares)551.05292.10
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
105515410292282
20110210920584574
30165316430876866
4022042194011681158
5027552745014611450
6033063296017531742
7038573847020452034
8044084398023372326
9049594949026292618
10055105500029212910

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%1.02.00.033.3%1.04.00.020.0%1.09.00.010.0%1.024.00.04.0%
Book Value Change Per Share1.00.00.0100.0%2.01.00.066.7%4.01.00.080.0%5.05.00.050.0%13.012.00.052.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.025.00.0%
Total Gains per Share1.00.00.0100.0%2.01.00.066.7%4.01.00.080.0%5.05.00.050.0%13.012.00.052.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Futura Medical compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--1.0811.0810%0.249+334%-0.106+110%0.573+89%-0.032+103%
Book Value Per Share--2.8842.8840%1.803+60%2.080+39%1.944+48%2.137+35%
Current Ratio--2.4712.4710%1.472+68%2.325+6%2.900-15%6.319-61%
Debt To Asset Ratio--0.3400.3400%0.537-37%0.383-11%0.359-5%0.322+6%
Debt To Equity Ratio--0.5160.5160%1.158-55%0.682-24%0.631-18%9.401-95%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--10032685030.60010032685030.6000%7885130208.000+27%11233737452.600-11%10225957206.120-2%9468814782.900+6%
Eps--0.4160.4160%-2.144+615%-1.217+393%-1.215+392%-1.512+463%
Ev To Ebitda Ratio--71.01971.0190%-11.539+116%12.143+485%-0.293+100%-8.363+112%
Ev To Sales Ratio--7.2047.2040%25.428-72%16.316-56%16.316-56%942.752-99%
Free Cash Flow Per Share---0.415-0.4150%-0.308-26%-0.956+131%-1.156+179%-1.378+232%
Free Cash Flow To Equity Per Share---0.360-0.3600%1.190-130%-0.420+17%0.266-235%-0.102-72%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--7.872----------
Intrinsic Value_10Y_min---7.936----------
Intrinsic Value_1Y_max---0.581----------
Intrinsic Value_1Y_min---1.244----------
Intrinsic Value_3Y_max---0.702----------
Intrinsic Value_3Y_min---3.371----------
Intrinsic Value_5Y_max--0.436----------
Intrinsic Value_5Y_min---5.080----------
Market Cap2385065625.600-312%9835799730.6009835799730.6000%7747665408.000+27%11046520652.600-11%9942697866.120-1%9051026472.900+9%
Net Profit Margin--0.0930.0930%-2.100+2362%-0.669+821%-0.401+532%-48.753+52608%
Operating Margin--0.0930.0930%-2.246+2523%-0.718+874%-0.431+565%-60.110+64948%
Operating Ratio--0.9160.9160%3.246-72%1.387-34%0.832+10%60.710-98%
Pb Ratio2.722-303%10.97410.9740%14.146-22%19.360-43%24.929-56%95.393-88%
Pe Ratio18.867-303%76.06976.0690%-11.896+116%12.522+507%-1.152+102%-9.995+113%
Price Per Share7.850-303%31.65031.6500%25.500+24%36.117-12%32.580-3%29.718+7%
Price To Free Cash Flow Ratio-18.932+75%-76.332-76.3320%-82.810+8%-61.005-20%-44.202-42%-32.030-58%
Price To Total Gains Ratio7.258-303%29.26529.2650%102.311-71%33.498-13%34.376-15%7.192+307%
Quick Ratio--2.3522.3520%1.398+68%2.223+6%2.923-20%9.504-75%
Return On Assets--0.0950.0950%-0.551+679%-0.453+576%-0.653+787%-0.723+860%
Return On Equity--0.1440.1440%-1.189+924%-0.761+628%-1.123+878%-17.431+12183%
Total Gains Per Share--1.0811.0810%0.249+334%-0.106+110%0.573+89%-0.032+103%
Usd Book Value--12228886.61612228886.6160%7472571.844+64%8713605.524+40%8114729.432+51%8884874.290+38%
Usd Book Value Change Per Share--0.0150.0150%0.003+334%-0.001+110%0.008+89%0.000+103%
Usd Book Value Per Share--0.0390.0390%0.025+60%0.028+39%0.027+48%0.029+35%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--136885954.558136885954.5580%107584716.558+27%153273113.803-11%139522960.120-2%129192508.898+6%
Usd Eps--0.0060.0060%-0.029+615%-0.017+393%-0.017+392%-0.021+463%
Usd Free Cash Flow---1758097.620-1758097.6200%-1276527.182-27%-3975037.957+126%-4798569.422+173%-5717125.389+225%
Usd Free Cash Flow Per Share---0.006-0.0060%-0.004-26%-0.013+131%-0.016+179%-0.019+232%
Usd Free Cash Flow To Equity Per Share---0.005-0.0050%0.016-130%-0.006+17%0.004-235%-0.001-72%
Usd Market Cap32541835.396-312%134199651.524134199651.5240%105709146.827+27%150718727.784-11%135658169.685-1%123492205.196+9%
Usd Price Per Share0.107-303%0.4320.4320%0.348+24%0.493-12%0.445-3%0.405+7%
Usd Profit--1764182.8441764182.8440%-8886199.396+604%-5032991.443+385%-5029852.959+385%-6264120.990+455%
Usd Revenue--19000800.85719000800.8570%4230960.739+349%7743920.532+145%4646352.319+309%2404268.319+690%
Usd Total Gains Per Share--0.0150.0150%0.003+334%-0.001+110%0.008+89%0.000+103%
 EOD+3 -5MRQTTM+0 -0YOY+27 -103Y+29 -85Y+24 -1310Y+29 -8

3.3 Fundamental Score

Let's check the fundamental score of Futura Medical based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1518.867
Price to Book Ratio (EOD)Between0-12.722
Net Profit Margin (MRQ)Greater than00.093
Operating Margin (MRQ)Greater than00.093
Quick Ratio (MRQ)Greater than12.352
Current Ratio (MRQ)Greater than12.471
Debt to Asset Ratio (MRQ)Less than10.340
Debt to Equity Ratio (MRQ)Less than10.516
Return on Equity (MRQ)Greater than0.150.144
Return on Assets (MRQ)Greater than0.050.095
Total7/10 (70.0%)

3.4 Technical Score

Let's check the technical score of Futura Medical based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5040.715
Ma 20Greater thanMa 508.495
Ma 50Greater thanMa 1008.837
Ma 100Greater thanMa 20010.210
OpenGreater thanClose8.000
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Futura Medical

Futura Medical plc research, develops, and sells pharmaceutical and healthcare products for sexual health. Its lead product is Eroxon, a topical gel for the treatment of erectile dysfunction. It also develops WSD4000 for the treatment of sexual dysfunction in women. The company operates in the United Kingdom, the European Union, the United States, and internationally. Futura Medical plc was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.

Fundamental data was last updated by Penke on 2025-06-29 12:32:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Futura Medical earns for each 1 of revenue.

  • Above 10% is considered healthy but always compareΒ Futura Medical to theΒ Biotechnology industry mean.
  • A Net Profit Margin of 9.3%Β means thatΒ 0.09 for each 1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Futura Medical:

  • The MRQ is 9.3%. The company is making a profit. +1
  • The TTM is 9.3%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ9.3%TTM9.3%0.0%
TTM9.3%YOY-210.0%+219.3%
TTM9.3%5Y-40.1%+49.4%
5Y-40.1%10Y-4,875.3%+4,835.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ9.3%-91.7%+101.0%
TTM9.3%-139.0%+148.3%
YOY-210.0%-194.4%-15.6%
3Y-66.9%-248.5%+181.6%
5Y-40.1%-343.3%+303.2%
10Y-4,875.3%-488.9%-4,386.4%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Futura Medical is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Futura Medical to theΒ Biotechnology industry mean.
  • 9.5% Return on Assets means thatΒ Futura Medical generatedΒ 0.10 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Futura Medical:

  • The MRQ is 9.5%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 9.5%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ9.5%TTM9.5%0.0%
TTM9.5%YOY-55.1%+64.6%
TTM9.5%5Y-65.3%+74.8%
5Y-65.3%10Y-72.3%+7.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ9.5%-11.6%+21.1%
TTM9.5%-11.7%+21.2%
YOY-55.1%-11.4%-43.7%
3Y-45.3%-11.9%-33.4%
5Y-65.3%-12.1%-53.2%
10Y-72.3%-13.8%-58.5%
4.3.1.3. Return on Equity

Shows how efficient Futura Medical is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Futura Medical to theΒ Biotechnology industry mean.
  • 14.4% Return on Equity means Futura Medical generated 0.14Β for eachΒ 1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Futura Medical:

  • The MRQ is 14.4%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 14.4%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ14.4%TTM14.4%0.0%
TTM14.4%YOY-118.9%+133.3%
TTM14.4%5Y-112.3%+126.7%
5Y-112.3%10Y-1,743.1%+1,630.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ14.4%-13.5%+27.9%
TTM14.4%-15.0%+29.4%
YOY-118.9%-14.5%-104.4%
3Y-76.1%-16.9%-59.2%
5Y-112.3%-17.9%-94.4%
10Y-1,743.1%-19.9%-1,723.2%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Futura Medical.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Futura Medical is operatingΒ .

  • Measures how much profit Futura Medical makes for each 1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Futura Medical to theΒ Biotechnology industry mean.
  • An Operating Margin of 9.3%Β means the company generated 0.09 Β for each 1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Futura Medical:

  • The MRQ is 9.3%. The company is operating less efficient.
  • The TTM is 9.3%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ9.3%TTM9.3%0.0%
TTM9.3%YOY-224.6%+233.8%
TTM9.3%5Y-43.1%+52.3%
5Y-43.1%10Y-6,011.0%+5,967.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ9.3%-229.2%+238.5%
TTM9.3%-249.7%+259.0%
YOY-224.6%-208.4%-16.2%
3Y-71.8%-221.7%+149.9%
5Y-43.1%-344.1%+301.0%
10Y-6,011.0%-470.4%-5,540.6%
4.3.2.2. Operating Ratio

Measures how efficient Futura Medical is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Biotechnology industry mean).
  • An Operation Ratio of 0.92 means that the operating costs are 0.92 for each 1 in net sales.

Let's take a look of the Operating Ratio trends of Futura Medical:

  • The MRQ is 0.916. The company is less efficient in keeping operating costs low.
  • The TTM is 0.916. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.916TTM0.9160.000
TTM0.916YOY3.246-2.330
TTM0.9165Y0.832+0.083
5Y0.83210Y60.710-59.878
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9162.108-1.192
TTM0.9162.680-1.764
YOY3.2463.080+0.166
3Y1.3873.621-2.234
5Y0.8324.734-3.902
10Y60.7106.546+54.164
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Futura Medical.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Futura Medical is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Biotechnology industry mean).
  • A Current Ratio of 2.47Β means the company has 2.47 in assets for each 1 in short-term debts.

Let's take a look of the Current Ratio trends of Futura Medical:

  • The MRQ is 2.471. The company is able to pay all its short-term debts. +1
  • The TTM is 2.471. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.471TTM2.4710.000
TTM2.471YOY1.472+0.999
TTM2.4715Y2.900-0.429
5Y2.90010Y6.319-3.419
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.4713.659-1.188
TTM2.4713.834-1.363
YOY1.4724.141-2.669
3Y2.3254.661-2.336
5Y2.9005.756-2.856
10Y6.3196.151+0.168
4.4.3.2. Quick Ratio

Measures if Futura Medical is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Futura Medical to theΒ Biotechnology industry mean.
  • A Quick Ratio of 2.35Β means the company can pay off 2.35 for each 1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Futura Medical:

  • The MRQ is 2.352. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.352. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.352TTM2.3520.000
TTM2.352YOY1.398+0.955
TTM2.3525Y2.923-0.571
5Y2.92310Y9.504-6.581
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.3522.799-0.447
TTM2.3523.143-0.791
YOY1.3983.794-2.396
3Y2.2234.307-2.084
5Y2.9235.707-2.784
10Y9.5046.457+3.047
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Futura Medical.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of Futura MedicalΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Futura Medical to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.34Β means that Futura Medical assets areΒ financed with 34.0% credit (debt) and the remaining percentage (100% - 34.0%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Futura Medical:

  • The MRQ is 0.340. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.340. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.340TTM0.3400.000
TTM0.340YOY0.537-0.196
TTM0.3405Y0.359-0.019
5Y0.35910Y0.322+0.037
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3400.324+0.016
TTM0.3400.347-0.007
YOY0.5370.329+0.208
3Y0.3830.340+0.043
5Y0.3590.349+0.010
10Y0.3220.379-0.057
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Futura Medical is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Futura Medical to theΒ Biotechnology industry mean.
  • A Debt to Equity ratio of 51.6% means that company has 0.52 debt for each 1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Futura Medical:

  • The MRQ is 0.516. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.516. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.516TTM0.5160.000
TTM0.516YOY1.158-0.641
TTM0.5165Y0.631-0.115
5Y0.63110Y9.401-8.770
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5160.379+0.137
TTM0.5160.435+0.081
YOY1.1580.412+0.746
3Y0.6820.446+0.236
5Y0.6310.460+0.171
10Y9.4010.509+8.892
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every 1 in earnings Futura Medical generates.

  • Above 15 is considered overpriced butΒ always compareΒ Futura Medical to theΒ Biotechnology industry mean.
  • A PE ratio of 76.07 means the investor is paying 76.07Β for every 1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Futura Medical:

  • The EOD is 18.867. Based on the earnings, the company is fair priced.
  • The MRQ is 76.069. Based on the earnings, the company is expensive. -2
  • The TTM is 76.069. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD18.867MRQ76.069-57.202
MRQ76.069TTM76.0690.000
TTM76.069YOY-11.896+87.965
TTM76.0695Y-1.152+77.221
5Y-1.15210Y-9.995+8.844
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD18.867-2.282+21.149
MRQ76.069-2.062+78.131
TTM76.069-2.541+78.610
YOY-11.896-3.722-8.174
3Y12.522-3.754+16.276
5Y-1.152-6.100+4.948
10Y-9.995-6.653-3.342
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Futura Medical:

  • The EOD is -18.932. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -76.332. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -76.332. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-18.932MRQ-76.332+57.400
MRQ-76.332TTM-76.3320.000
TTM-76.332YOY-82.810+6.478
TTM-76.3325Y-44.202-32.130
5Y-44.20210Y-32.030-12.172
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-18.932-3.101-15.831
MRQ-76.332-2.689-73.643
TTM-76.332-3.594-72.738
YOY-82.810-4.363-78.447
3Y-61.005-5.065-55.940
5Y-44.202-8.478-35.724
10Y-32.030-9.273-22.757
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Futura Medical is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Biotechnology industry mean).
  • A PB ratio of 10.97 means the investor is paying 10.97Β for each 1 in book value.

Let's take a look of the Price to Book Ratio trends of Futura Medical:

  • The EOD is 2.722. Based on the equity, the company is underpriced. +1
  • The MRQ is 10.974. Based on the equity, the company is expensive. -2
  • The TTM is 10.974. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD2.722MRQ10.974-8.252
MRQ10.974TTM10.9740.000
TTM10.974YOY14.146-3.172
TTM10.9745Y24.929-13.955
5Y24.92910Y95.393-70.465
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD2.7221.932+0.790
MRQ10.9741.848+9.126
TTM10.9742.119+8.855
YOY14.1462.469+11.677
3Y19.3602.526+16.834
5Y24.9293.667+21.262
10Y95.3934.351+91.042
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2020-12-312021-12-312022-12-312023-12-312024-12-31
Other Current Liabilities  51,95329,54981,50362,190143,693382,470526,163-685,261-159,098
Income before Tax  -292,747-293,884-586,631-100,518-687,149-2,048-689,197818,282129,085
Net Income  -240,838-254,933-495,771-88,878-584,650-66,640-651,290780,591129,301
EBIT  -292,747-293,884-586,631-100,518-687,149-9,228-696,377825,462129,085
EBITDA  -290,246-294,404-584,650-100,026-684,6761,326-683,350824,618141,268
Operating Income  -292,839-293,792-586,631-100,518-687,149-9,228-696,377813,946117,569
Net Income from Continuing Operations  -240,838-254,933-495,771-88,878-584,650-66,640-651,290780,591129,301



6.2. Latest Balance Sheet

Balance Sheet of 2024-12-31. Currency in GBP. All numbers in thousands.

Summary
Total Assets13,590
Total Liabilities4,627
Total Stockholder Equity8,963
 As reported
Total Liabilities 4,627
Total Stockholder Equity+ 8,963
Total Assets = 13,590

Assets

Total Assets13,590
Total Current Assets9,501
Long-term Assets4,090
Total Current Assets
Cash And Cash Equivalents 6,596
Net Receivables 2,448
Inventory 456
Total Current Assets  (as reported)9,501
Total Current Assets  (calculated)9,501
+/-0
Long-term Assets
Property Plant Equipment 4,090
Long-term Assets Other 0
Long-term Assets  (as reported)4,090
Long-term Assets  (calculated)4,090
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities3,845
Long-term Liabilities783
Total Stockholder Equity8,963
Total Current Liabilities
Accounts payable 1,493
Other Current Liabilities -1,591
Total Current Liabilities  (as reported)3,845
Total Current Liabilities  (calculated)-98
+/- 3,942
Long-term Liabilities
Long-term Liabilities  (as reported)783
Long-term Liabilities  (calculated)0
+/- 783
Total Stockholder Equity
Common Stock607
Retained Earnings -62,880
Other Stockholders Equity 71,235
Total Stockholder Equity (as reported)8,963
Total Stockholder Equity (calculated)8,963
+/-0
Other
Capital Stock607
Cash and Short Term Investments 6,596
Common Stock Shares Outstanding 310,768
Current Deferred Revenue98
Liabilities and Stockholders Equity 13,590
Net Debt -6,596
Net Invested Capital 8,963
Net Working Capital 5,656
Property Plant and Equipment Gross 4,527



6.3. Balance Sheets Structured

Currency in GBP. All numbers in thousands.

 Trend2024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312003-01-312002-01-312001-01-31
> Total Assets 
336
2,261
1,766
2,589
3,973
2,217
4,184
3,088
1,038
2,077
1,053
2,952
3,208
1,466
10,330
5,515
13,439
9,605
10,878
4,901
1,620
11,803
6,473
11,816
13,590
13,59011,8166,47311,8031,6204,90110,8789,60513,4395,51510,3301,4663,2082,9521,0532,0771,0383,0884,1842,2173,9732,5891,7662,261336
   > Total Current Assets 
334
2,218
1,734
2,567
3,945
2,192
4,164
3,053
1,018
2,067
1,045
2,947
3,202
1,458
10,319
5,495
13,418
9,541
10,830
4,842
1,577
11,360
5,315
9,332
9,501
9,5019,3325,31511,3601,5774,84210,8309,54113,4185,49510,3191,4583,2022,9471,0452,0671,0183,0534,1642,1923,9452,5671,7342,218334
       Cash And Cash Equivalents 
290
2,043
1,511
2,402
3,672
1,809
2,741
2,638
782
1,789
825
2,582
2,817
991
9,492
4,188
12,353
8,363
9,158
2,511
1,019
10,373
4,026
7,714
6,596
6,5967,7144,02610,3731,0192,5119,1588,36312,3534,1889,4929912,8172,5828251,7897822,6382,7411,8093,6722,4021,5112,043290
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12,206
8,194
3,451
373
374
0
0
0
0
00003743733,4518,19412,2060000000000000000
       Net Receivables 
0
175
223
116
203
310
-1
322
60
186
64
0
291
353
592
1,047
877
1,108
1,665
2,282
535
916
1,093
1,148
2,448
2,4481,1481,0939165352,2821,6651,1088771,04759235329106418660322-13102031162231750
       Other Current Assets 
44
175
223
148
258
351
1,391
392
226
267
211
356
377
432
685
1,143
104
1,108
1,665
41
24
72
196
469
0
04691967224411,6651,1081041,1436854323773562112672263921,39135125814822317544
   > Long-term Assets 
2
43
32
22
28
25
20
35
20
10
8
5
7
8
11
20
21
64
47
60
43
443
1,158
2,485
4,090
4,0902,4851,1584434360476421201187581020352025282232432
       Property Plant Equipment 
2
43
32
22
28
25
20
35
20
10
8
5
7
8
11
20
21
64
47
60
43
443
1,158
2,485
4,090
4,0902,4851,1584434360476421201187581020352025282232432
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000
> Total Liabilities 
630
262
247
180
225
237
236
315
152
224
152
194
335
478
608
729
855
499
2,026
4,848
767
2,078
1,753
6,340
4,627
4,6276,3401,7532,0787674,8482,026499855729608478335194152224152315236237225180247262630
   > Total Current Liabilities 
103
262
235
180
225
237
236
315
152
224
152
194
335
478
608
729
855
499
2,026
4,848
767
2,078
1,753
6,340
3,845
3,8456,3401,7532,0787674,8482,026499855729608478335194152224152315236237225180235262103
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
218
0
0
432
0
0
00432002180000000000000000000
       Accounts payable 
58
163
146
68
79
115
123
99
71
83
76
97
165
187
396
461
286
131
1,246
2,625
183
981
316
1,006
1,493
1,4931,0063169811832,6251,2461312864613961871659776837199123115796814616358
       Other Current Liabilities 
45
99
89
112
124
91
76
178
49
116
52
70
141
243
172
200
526
236
737
2,222
520
815
1,437
5,262
-1,591
-1,5915,2621,4378155202,2227372365262001722431417052116491787691124112899945
   > Long-term Liabilities 
527
163
12
180
79
115
123
99
71
83
76
97
165
187
396
461
286
131
1,246
2,625
183
981
316
0
783
78303169811832,6251,24613128646139618716597768371991231157918012163527
       Other Liabilities 
0
0
12
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000001200
> Total Stockholder Equity
-294
1,999
1,519
2,409
3,748
1,980
3,948
2,773
886
1,853
901
2,758
2,873
988
9,722
4,786
12,584
9,106
8,852
54
854
9,725
4,720
5,477
8,963
8,9635,4774,7209,725854548,8529,10612,5844,7869,7229882,8732,7589011,8538862,7733,9481,9803,7482,4091,5191,999-294
   Common Stock
58
81
83
91
97
98
111
115
115
135
135
146
155
156
198
198
240
241
409
409
491
574
576
603
607
607603576574491409409241240198198156155146135135115115111989791838158
   Retained Earnings -62,880-67,347-63,720-58,546-53,770-51,511-42,693-36,959-33,260-29,617-24,657-21,836-19,769-17,722-16,010-14,991-13,642-11,755-9,566-7,831-5,927-4,698-3,337-2,252-1,002
   Accumulated Other Comprehensive Income 
-2
-11
-23
-36
-35
-49
-59
-74
-91
-102
-95
-98
-100
-104
-76
-83
-89
-91
-102
-123
166
166
166
0
0
00166166166-123-102-91-89-83-76-104-100-98-95-102-91-74-59-49-35-36-23-11-2
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
44,452
44,671
49,984
50,003
52,814
0
0
0
0
000052,81450,00349,98444,67144,4520000000000000000
   Treasury Stock0000000000000000000000000
   Other Stockholders Equity 
652
4,170
4,773
7,016
9,578
9,713
13,403
14,413
14,413
16,709
16,775
19,181
21,336
21,516
33,029
33,053
44,452
44,671
49,984
51,155
52,814
66,378
67,698
72,221
71,235
71,23572,22167,69866,37852,81451,15549,98444,67144,45233,05333,02921,51621,33619,18116,77516,70914,41314,41313,4039,7139,5787,0164,7734,170652



6.4. Balance Sheets

Currency in GBP. All numbers in thousands.




6.5. Cash Flows

Currency in GBP. All numbers in thousands.




6.6. Income Statements

Currency in GBP. All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in GBP. All numbers in thousands.

Gross Profit (+$)
totalRevenue13,926
Cost of Revenue-4,359
Gross Profit9,5689,568
 
Operating Income (+$)
Gross Profit9,568
Operating Expense-8,392
Operating Income1,1761,176
 
Operating Expense (+$)
Research Development1,742
Selling General Administrative6,831
Selling And Marketing Expenses0
Operating Expense8,3928,573
 
Net Interest Income (+$)
Interest Income47
Interest Expense-0
Other Finance Cost-0
Net Interest Income47
 
Pretax Income (+$)
Operating Income1,176
Net Interest Income47
Other Non-Operating Income Expenses0
Income Before Tax (EBT)1,2911,061
EBIT - interestExpense = 1,291
1,291
1,293
Interest Expense0
Earnings Before Interest and Taxes (EBIT)1,2911,291
Earnings Before Interest and Taxes (EBITDA)1,413
 
After tax Income (+$)
Income Before Tax1,291
Tax Provision--2
Net Income From Continuing Ops1,2931,293
Net Income1,293
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses12,750
Total Other Income/Expenses Net115-47
 

Technical Analysis of Futura Medical
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Futura Medical. The general trend of Futura Medical is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Futura Medical's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Futura Medical Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Futura Medical.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 8 < 8 < 9.98.

The bearish price targets are: .

Know someone who trades $FUM? Share this with them.πŸ‘‡

Futura Medical Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Futura Medical. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Futura Medical Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Futura Medical. The current macd is -0.41043655.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Futura Medical price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Futura Medical. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Futura Medical price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Futura Medical Daily Moving Average Convergence/Divergence (MACD) ChartFutura Medical Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Futura Medical. The current adx is 14.83.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Futura Medical shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Futura Medical Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Futura Medical. The current sar is 8.352.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Futura Medical Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Futura Medical. The current rsi is 40.72. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Futura Medical Daily Relative Strength Index (RSI) ChartFutura Medical Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Futura Medical. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Futura Medical price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Futura Medical Daily Stochastic Oscillator ChartFutura Medical Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Futura Medical. The current cci is -100.81706438.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Futura Medical Daily Commodity Channel Index (CCI) ChartFutura Medical Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Futura Medical. The current cmo is -18.21596558.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Futura Medical Daily Chande Momentum Oscillator (CMO) ChartFutura Medical Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Futura Medical. The current willr is -76.61870504.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Futura Medical is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Futura Medical Daily Williams %R ChartFutura Medical Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Futura Medical.

Futura Medical Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Futura Medical. The current atr is 0.93570868.

Futura Medical Daily Average True Range (ATR) ChartFutura Medical Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Futura Medical. The current obv is -20,778,457.

Futura Medical Daily On-Balance Volume (OBV) ChartFutura Medical Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Futura Medical. The current mfi is 44.66.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Futura Medical Daily Money Flow Index (MFI) ChartFutura Medical Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Futura Medical.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-13STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-17STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-18STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-02-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-24WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-17STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-18BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-24RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-26RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-03-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-31SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-04-03SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-04CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-04-07RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-14STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-04-15RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-16STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-17CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-24SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-04-30STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-01SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-05-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-06SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-09SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-13SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-14STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-05-15MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-05-16STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-05-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-23CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-05-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-05-28STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-06-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-03CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-06-05STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-09STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-06-17CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-06-18STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-19STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-06-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-06-23CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-24DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-06-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-27STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-06-30STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-01STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-02BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-07-03STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Futura Medical Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Futura Medical based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5040.715
Ma 20Greater thanMa 508.495
Ma 50Greater thanMa 1008.837
Ma 100Greater thanMa 20010.210
OpenGreater thanClose8.000
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Futura Medical with someone you think should read this too:
  • Are you bullish or bearish on Futura Medical? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Futura Medical? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Futura Medical

I send you an email if I find something interesting about Futura Medical.


Comments

How you think about this?

Leave a comment

Stay informed about Futura Medical.

Receive notifications about Futura Medical in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.